Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Xarelto image

Bayer promotes Xarelto benefits

June 15, 2015
Sales and Marketing Bayer, Eliquis, Xarelto, blood, law suits, rivaroxaban

Bayer HealthCare is releasing new evidence to suggest that the risk of taking its best-selling blood thinner Xarelto is outweighed …

News
Panasonic image

Panasonic snaps up Bayer diabetes

June 12, 2015
Medical Communications, Sales and Marketing Bayer, panasonic

Bayer is selling off its Diabetes Care business to Panasonic Healthcare Holdings, giving the Japanese giant access to blood glucose …

News
xofigo image

NICE issues guidance for two prostate cancer drugs

June 5, 2015
Sales and Marketing Bayer, Ferring, NICE, firmagon, xofigo

NICE has published draft guidance for two prostate cancer drugs, recommending a Bayer medicine but rejecting one from Ferring Pharmaceuticals. …

News
Bayer image

Bayer and Gilead expand in manufacturing

June 2, 2015
Manufacturing and Production, Sales and Marketing Bayer, Gilead, brett wells, manufacturing

Both Bayer and Gilead are investing heavily into their manufacturing operations with expansion plans being laid down in Indonesia and …

News
Roche logo

NICE signs-off Roche’s Gazyvaro for leukaemia

June 2, 2015
Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia

NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …

News
Bayer image

Bayer wins Cancer Drugs Fund appeal

May 22, 2015
Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …

News
bayer_chimney

Bayer buys blood-thinning drug from Isis

May 5, 2015
Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …

News
Bayer image

Profits fall at Bayer but new drugs see growth

May 1, 2015
Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban

Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …

News
Boehringer image

Boehringer Ingelheim and Bayer ‘taking the lead’ in social media

April 22, 2015
Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld

Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …

News
Keytruda image

Drug development showcasing at AACR conference

April 13, 2015
Research and Development, Sales and Marketing American Association of Cancer Research, AstraZeneca, Bayer, Genentech, Novartis, aacr

This month’s American Association of Cancer Research conference is set to showcase the latest studies in oncology. Roche’s biotech subsidiary …

News
Bayer image

Bayer and Regeneron eye drug gains another indication

March 26, 2015
Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept

Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …

News
NICE image

NICE decisions made on Bayer, Celgene and Boehringer drugs

March 26, 2015
Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance

In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …

News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015
Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …

News
Baye image

New EU indication for Bayer and Regeneron eye drug

February 27, 2015
Sales and Marketing Bayer, European Commission, Eylea, aflibercept

Bayer and Regeneron’s Eylea is now indicated for every type of the eye disease retinal vein occlusion (RVO) thanks to …

News
Christopher Viehbacher image

Ousted Sanofi boss finds role at PureTech

February 27, 2015
Sales and Marketing Bayer, Sanofi, Viehbacher, baumann, brandicourt, pott, puretech

US science and technology R&D company PureTech has appointed the former Sanofi chief executive Christopher Viehbacher to its board. Viehbacher …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025